Media Center

Recent News

09/19/17ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26, 2017Printer Friendly Version
08/08/17ACADIA Pharmaceuticals Reports Second Quarter 2017 Financial ResultsPrinter Friendly Version
08/01/17ACADIA Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 8, 2017Printer Friendly Version
07/25/17ACADIA Pharmaceuticals Named to Forbes Magazine’s List of World’s Most Innovative Growth CompaniesPrinter Friendly Version
05/09/17ACADIA Pharmaceuticals Reports First Quarter 2017 Financial ResultsPrinter Friendly Version
2017 | 2016 | 2015 | Archive

Company Information

Annual Report
Corporate Presentation


Scientific Publications

Pimavanserin for patients with Parkinson's disease psychosis: a randomized, placebo-controlled phase 3 trial. The Lancet, 383, 533-540 (2014).